SG10201705118RA - Dna element having the activity of enhancing foreign gene expression - Google Patents

Dna element having the activity of enhancing foreign gene expression

Info

Publication number
SG10201705118RA
SG10201705118RA SG10201705118RA SG10201705118RA SG10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA
Authority
SG
Singapore
Prior art keywords
activity
gene expression
foreign gene
dna element
enhancing foreign
Prior art date
Application number
SG10201705118RA
Other languages
English (en)
Inventor
Nishimiya Daisuke
Inoue Tatsuya
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of SG10201705118RA publication Critical patent/SG10201705118RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51Complete heavy chain or Fd fragment, i.e. VH + CH1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515Complete light chain, i.e. VL + CL
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/106Plasmid DNA for vertebrates
    • C12N2800/107Plasmid DNA for vertebrates for mammalian
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/46Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10201705118RA 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression SG10201705118RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010154782 2010-07-07

Publications (1)

Publication Number Publication Date
SG10201705118RA true SG10201705118RA (en) 2017-07-28

Family

ID=44630215

Family Applications (4)

Application Number Title Priority Date Filing Date
SG10201705118RA SG10201705118RA (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG10201505354PA SG10201505354PA (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG2012094330A SG186788A1 (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG2014009187A SG2014009187A (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression

Family Applications After (3)

Application Number Title Priority Date Filing Date
SG10201505354PA SG10201505354PA (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG2012094330A SG186788A1 (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression
SG2014009187A SG2014009187A (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression

Country Status (14)

Country Link
US (3) US9371543B2 (pt)
EP (3) EP3026117B1 (pt)
JP (2) JP5859988B2 (pt)
KR (3) KR101833570B1 (pt)
CN (3) CN105950621B (pt)
AU (3) AU2011274864B2 (pt)
BR (1) BR112012033780A2 (pt)
CA (2) CA2804381C (pt)
ES (3) ES2701091T3 (pt)
IL (1) IL243763A0 (pt)
RU (1) RU2013104989A (pt)
SG (4) SG10201705118RA (pt)
TW (2) TW201604280A (pt)
WO (1) WO2012005378A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201705118RA (en) * 2010-07-07 2017-07-28 Daiichi Sankyo Co Ltd Dna element having the activity of enhancing foreign gene expression
TW201632625A (zh) 2011-11-28 2016-09-16 第一三共股份有限公司 源自人類基因的啟動子
CN109790539A (zh) * 2016-10-03 2019-05-21 第一三共株式会社 Hspa5基因的启动子
CN107881174B (zh) * 2017-11-22 2022-06-03 张宝会 一种翻译水平基因表达调控的方法及应用
KR20230009388A (ko) * 2020-05-11 2023-01-17 삼성바이오에피스 주식회사 인간 게놈 유래 폴리뉴클레오타이드 및 이를 이용한 목적 폴리펩타이드의 생산 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0414689B1 (en) * 1988-02-12 1994-12-07 Commonwealth Scientific And Industrial Research Organisation Pox virus vectors
US20070161003A1 (en) * 2003-09-29 2007-07-12 Morris David W Novel therapeutic targets in cancer
EP2105742A1 (en) * 2008-03-26 2009-09-30 Sanofi-Aventis Use of cathepsin C
JP5344682B2 (ja) * 2008-12-26 2013-11-20 グローブライド株式会社 釣糸ガイド、及び釣糸ガイドの製造方法
SG10201705118RA (en) * 2010-07-07 2017-07-28 Daiichi Sankyo Co Ltd Dna element having the activity of enhancing foreign gene expression
TW201632625A (zh) * 2011-11-28 2016-09-16 第一三共股份有限公司 源自人類基因的啟動子

Also Published As

Publication number Publication date
KR20180021247A (ko) 2018-02-28
ES2701091T3 (es) 2019-02-20
US11060108B2 (en) 2021-07-13
AU2011274864A1 (en) 2013-02-07
KR101856927B1 (ko) 2018-05-10
ES2564227T3 (es) 2016-03-21
SG186788A1 (en) 2013-02-28
WO2012005378A3 (en) 2012-04-12
EP2591113B1 (en) 2016-01-20
KR20180021246A (ko) 2018-02-28
CN103865931B (zh) 2018-10-02
AU2011274864B2 (en) 2016-10-06
JP2013531967A (ja) 2013-08-15
IL243763A0 (en) 2016-04-21
EP2684961B1 (en) 2016-01-20
CN105950621B (zh) 2019-07-30
CA2804381C (en) 2016-03-22
AU2018200686A1 (en) 2018-02-22
AU2016203681A1 (en) 2016-06-23
CN105950621A (zh) 2016-09-21
EP2684961A1 (en) 2014-01-15
SG10201505354PA (en) 2015-08-28
EP2591113A2 (en) 2013-05-15
JP5859988B2 (ja) 2016-02-16
AU2018200686B2 (en) 2020-02-13
TW201604280A (zh) 2016-02-01
US10407694B2 (en) 2019-09-10
EP3026117A1 (en) 2016-06-01
SG2014009187A (en) 2014-04-28
US9371543B2 (en) 2016-06-21
US20130171694A1 (en) 2013-07-04
JP2016054741A (ja) 2016-04-21
KR20130111514A (ko) 2013-10-10
BR112012033780A2 (pt) 2016-05-31
ES2565428T3 (es) 2016-04-04
TW201207103A (en) 2012-02-16
AU2016203681B2 (en) 2018-04-19
WO2012005378A2 (en) 2012-01-12
JP6039048B2 (ja) 2016-12-07
KR101920187B1 (ko) 2018-11-19
RU2013104989A (ru) 2014-08-20
CN103080321A (zh) 2013-05-01
CA2804381A1 (en) 2012-01-12
CN103865931A (zh) 2014-06-18
CA2916937A1 (en) 2012-01-12
US20190345515A1 (en) 2019-11-14
KR101833570B1 (ko) 2018-03-02
TWI507523B (zh) 2015-11-11
EP3026117B1 (en) 2018-09-12
US20160333371A1 (en) 2016-11-17

Similar Documents

Publication Publication Date Title
SI2612917T1 (sl) Protismiselna nukleinska kislina
HK1198704A1 (zh) 具有改進活性的 聚合酶
EP2791159A4 (en) MODIFIED NUCLEIC ACIDS, AND SHORT-TERM CARE USES THEREOF
EP2632260A4 (en) ACTIVITY OF THE REPELLENT ENZYME KINASE RICH IN LEUCINE
HK1207880A1 (en) Improved enzyme variants
EP2599866A4 (en) NEW NUCLEIC ACID WITH ADJUVANS ACTIVITY AND ITS USE
EP2487238A4 (en) SUSCEPTIBILITY FOR HAIR FORMS
GB201004475D0 (en) Gene silencing
EP2554667A4 (en) NOVEL CELLULASEGEN
HK1188608A1 (en) Dna expression construct dna
IL226536A (en) DNA position-oriented change
IL243763A0 (en) A DNA element with the activity of increasing the expression of a foreign gene and its uses
EP2649993A4 (en) STABILIZER OF ACETAMINOPHENE
GB2502195B (en) Purification of nucleic acids
IL226537A (en) Position-directed change of DNA with oligonucleotides
HK1199064A1 (en) Promoter derived from human gene
EP2451976A4 (en) NANO-BIOSENSORS WITH NUCLEIC ACIDS
EP2702999A4 (en) FUNCTIONAL NUCLEIC ACID TARGETING THE BRAIN AND USE THEREOF
EP2536741A4 (en) THERAPY TARGETING FUSIONS OF GENES
ZA201400484B (en) Nucleic acid molecules encoding enzymes that confer disease resistance injute
EP2616813A4 (en) HOST-SUPPORTED GENETIC BIOSENSORS
EP2535415A4 (en) MODIFIED XYLANASE NUCLEOTIDE MOLECULES AND THEIR APPLICATIONS
GB201021720D0 (en) Gene variant
GB201010471D0 (en) Gene variant
GB201215484D0 (en) Optical characterisation of DNA and/or RNA